市場調查報告書

生物醫藥品添加劑的全球市場:市場規模·佔有率·趨勢分析,各部門預測 (各產品 (多元醇,可溶解劑及界面活性劑/乳化劑,碳水化合物)·各地區)

Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Product (Polyols, Solubilizers & Surfactants/Emulsifiers, Carbohydrates), By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 780059
出版日期 內容資訊 英文 160 Pages
商品交期: 2-3個工作天內
價格
生物醫藥品添加劑的全球市場:市場規模·佔有率·趨勢分析,各部門預測 (各產品 (多元醇,可溶解劑及界面活性劑/乳化劑,碳水化合物)·各地區) Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Product (Polyols, Solubilizers & Surfactants/Emulsifiers, Carbohydrates), By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年02月17日內容資訊: 英文 160 Pages
簡介

本報告提供全球生物醫藥品添加劑的市場相關分析,彙整市場基本結構和主要的促進·阻礙因素,各產品·各地區的市場趨勢預測 (今後6年份),主要企業的簡介與策略展開情形等資訊,為您概述為以下內容。

第1章 摘要整理

第2章 調查方法·範圍

第3章 變動要素·趨勢·範圍

  • 市場區隔·範圍
  • 產品普及率·成長率預測:製圖
  • 生物醫藥品添加劑市場:SWOT分析,要因別 (政治·法律·經濟·技術性要素)
  • 產業分析:波特的五力分析

第4章 生物醫藥品添加劑的市場區隔:估計值·趨勢分析,各產品

  • 全球生物醫藥品添加劑市場:各產品趨勢分析 (最新值·預測值)
  • 可溶解劑,界面活性劑/乳化劑
    • 三酸甘油酯
      • 市場規模,實際成果值·預測值 (以金額為準,總計12年份)
      • 市場規模,實際成果值·預測值 (以數量為準,總計12年份)
    • 酯類
    • 其他可溶解劑
  • 多元醇
    • 甘露醇
    • 山梨醇
    • 其他多元醇
  • 碳水化合物
    • 葡萄糖
    • 蔗糖
    • 澱粉
    • 其他碳水化合物賦形劑
  • 特殊賦形劑

第5章 生物醫藥品添加劑的市場區隔:估計值·趨勢分析,各地區

  • 生物醫藥品添加劑:各地區的市場佔有率 (最新值·預測值)
  • 北美
  • 歐洲
  • 亞太地區
  • 中南美
  • 中東·非洲地區(MEA)

第6章 競爭情形

  • 策略的組成架構
  • 市場參與企業的分類
  • 企業簡介
  • Merck KGaA
    • 企業概要
    • 財務實際成果
    • 產品間的互相比較
    • 策略展開情形
  • Signet Chemical Corporation Pvt. Ltd.
  • Sigachi Industries Pvt. Ltd.
  • Associated British Foods
  • Spectrum Chemical Manufacturing Corp.
  • Roquette Freres
  • IMCD
  • Clariant
  • DFE Pharma
  • Colorcon
  • J. RETTENMAIER & SOHNE GmbH + Co KG
  • BASF SE
  • Evonik Industries AG

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-3-68038-006-4

The global biopharmaceutical excipients market size is projected to reach USD 3.0 billion by 2027, exhibiting a CAGR of 5.9%, according to a new report by Grand View Research, Inc. The demand for biopharmaceutical excipients is anticipated to increase given that several biologicals will be expiring over the next few years. Rapidly evolving development and manufacturing of biosimilars are further contributing to the increasing demand for novel biopharmaceutical excipients. Continuous advancements in the pharmaceutical industry, reduced time taken for manufacturing products, and outsourcing also significantly drive the product demand.

The concept of multifunctional or smart excipients has piqued the interest of market participants owing to their enhanced compressibility and drug release ability. Moreover, they have the ability to overcome challenges associated with drug formulation such as complex drug manufacturing processes and high costs associated with incorporating these products in drugs. Maintaining drug stability while reducing overall costs associated with drug development is of utmost importance to achieve large-scale commercial biopharmaceutical manufacturing.

Thus, market players are investing in the development of multifunctional excipient products to sustain intensifying competition in the industry. Various commercial multifunctional/smart excipients include Ludipress (BASF SE), F-MELT (Fuji Chemical Industries Co., Ltd.), Galen IQ 721 (BENEO-Palatinit GmbH), and MCC SANAQ (Pharmatrans-Sanaq AG).

Further key findings from the report suggest:

  • Increasing focus of pharmaceutical players on utilizing recombinant protein and monoclonal antibodies for bio-generic drug development is expected to drive the biopharmaceutical excipients market growth in the coming years
  • Solubilizers and surfactants/emulsifiers accounted for a significant share in 2019 as they help maintain adequate efficacy of preservatives or antimicrobials in drug formulations
  • Polyols are anticipated to exhibit the fastest growth in terms of revenue from 2020 to 2027, as they are gaining significant traction across the latest drug formulations such as chewable tablets and lozenges
  • North America dominated the overall market in terms of revenue whereas Asia Pacific dominated the market in terms of volume in 2019
  • Key industry participants include Roquette Freres, Spectrum Chemical Manufacturing Corp., Merck KGaA, Colorcon, and BASF SE
  • Companies are inclined toward strategic agreements to maintain their market position. For instance, in February 2019, ABITEC (SPI Pharma) entered into a distribution agreement with Indchem International to distribute ABITEC's functional lipid excipient product line into the personal care, nutrition, and cosmeceutical markets in India

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Snapshot

Chapter 2 Methodology and Scope

  • 2.1 Market Segmentation & Scope
    • 2.1.1 Estimates and Forecast Timeline
  • 2.2 Research Methodology
  • 2.3 Information Procurement
    • 2.3.1 Purchased database:
    • 2.3.2 GVR's internal database
    • 2.3.3 Secondary sources:
    • 2.3.4 Primary Research:
    • 2.3.5 Details of Primary Research
      • 2.3.5.1 Data for primary interviews in North America
      • 2.3.5.2 Data for primary interviews in Europe
      • 2.3.5.3 Data for primary interviews in Asia Pacific
      • 2.3.5.4 Data for primary interviews in Latin America
      • 2.3.5.5 Data for primary interviews in MEA
  • 2.4 Information or Data Analysis
    • 2.4.1 Data Analysis Models
  • 2.5 Market Formulation & Validation
  • 2.6 Model Details
    • 2.6.1 Commodity Flow Analysis (Model 1)
      • 2.6.1.1 Approach 1: Commodity Flow Approach
    • 2.6.2 Volume Price Analysis (Model 2)
      • 2.6.2.1 Approach 2: Volume Price Analysis
  • 2.7 List of Secondary Sources
  • 2.8 List of Primary Sources
  • 2.9 Objectives
    • 2.9.1 Objective 1
    • 2.9.2 Objective 2

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Chemical and physical instability of biopharmaceuticals is boosting the development of excipients
      • 3.1.1.2 Increase in focus of pharmaceutical players on bio generic market
      • 3.1.1.3 Cost-efficiency and competency of manufacturers
      • 3.1.1.4 Patent expiry of biological actives
      • 3.1.1.5 Rising adoption of multifunctional excipients
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Challenges in development of excipients for biologics
      • 3.1.2.2 Issues pertaining to supply chain in biopharmaceutical industry
  • 3.2 Penetration & Growth Prospect Mapping for Products, 2018
  • 3.3 Biopharmaceutical Excipients Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4 Biopharmaceutical Excipients Market Categorization: Product Estimates & Trend Analysis

  • 4.1 Global Biopharmaceutical Excipients Market: Product Movement Analysis, 2019 & 2027
  • 4.2 Solubilizers & Surfactants/Emulsifiers
    • 4.2.1 Global solubilizers & surfactants/emulsifiers market, by revenue 2016 - 2027 (USD Million)
    • 4.2.2 Global solubilizers & surfactants/emulsifiers market, by volume 2016 - 2027 (Tones)
    • 4.2.3 Triglycerides
      • 4.2.3.1 Global triglycerides market, by revenue 2016 - 2027 (USD Million)
      • 4.2.3.2 Global triglycerides market, by volume 2016 - 2027 (Tones)
    • 4.2.4 Esters
      • 4.2.4.1 Global esters market, by revenue 2016 - 2027 (USD Million)
      • 4.2.4.2 Global esters market, by volume by 2016 - 2027 (Tones)
    • 4.2.5 Other solubilizers
      • 4.2.5.1 Global other solubilizers market, by revenue 2016 - 2027 (USD Million)
      • 4.2.5.2 Global other solubilizers market, by volume 2016 - 2027 (Tones)
  • 4.3 Polyols
    • 4.3.1 Global polyols market, by revenue 2016 - 2027 (USD Million)
    • 4.3.2 Global polyols market, by volume 2016 - 2027 (Tones)
    • 4.3.3 Mannitol
      • 4.3.3.1 Global mannitol market, by revenue 2016 - 2027 (USD Million)
      • 4.3.3.2 Global mannitol market, by volume 2016 - 2027 (Tones)
    • 4.3.4 Sorbitol
      • 4.3.4.1 Global sorbitol market, by revenue 2016 - 2027 (USD Million)
      • 4.3.4.2 Global sorbitol market, by volume 2016 - 2027 (Tones)
    • 4.3.5 Other polyols
      • 4.3.5.1 Global other polyols market, by revenue 2016 - 2027 (USD Million)
      • 4.3.5.2 Global other polyols market, by volume 2016 - 2027 (Tones)
  • 4.4 Carbohydrates
    • 4.4.1 Global carbohydrates market, by revenue 2016 - 2027 (USD Million)
    • 4.4.2 Global carbohydrates market, by volume 2016 - 2027 (Tones)
    • 4.4.3 Dextrose
      • 4.4.3.1 Global dextrose market, by revenue 2016 - 2027 (USD Million)
      • 4.4.3.2 Global dextrose market, by volume 2016 - 2027 (Tones)
    • 4.4.4 Sucrose
      • 4.4.4.1 Global sucrose market, by revenue 2016 - 2027 (USD Million)
      • 4.4.4.2 Global sucrose market, by volume 2016 - 2027 (Tones)
    • 4.4.5 Starch
      • 4.4.5.1 Global starch market, by revenue 2016 - 2027 (USD Million)
      • 4.4.5.2 Global starch market, by volume 2016 - 2027 (Tones)
    • 4.4.6 Other carbohydrate excipients
      • 4.4.6.1 Global other carbohydrates market, by revenue 2016 - 2027 (USD Million)
      • 4.4.6.2 Global other carbohydrates market, by volume 2016 - 2027 (Tones)
  • 4.5 Specialty Excipients
    • 4.5.1 Global specialty excipients market, by revenue 2016 - 2027 (USD Million)
    • 4.5.2 Global specialty excipients market, by volume 2016 - 2027 (Tones)

Chapter 5 Biopharmaceutical Excipients Market Categorization: Regional Estimates & Trend Analysis, by Product

  • 5.1 Biopharmaceutical Excipients Market Share By Region, 2019 & 2027
  • 5.2 North America
    • 5.2.1 North America biopharmaceutical excipients market, 2016 - 2027 (USD Million)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. biopharmaceutical excipients market, 2016 - 2027 (USD Million)
    • 5.2.3 Canada
      • 5.2.3.1 Canada biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe biopharmaceutical excipients market, 2016 - 2027 (USD Million)
    • 5.3.2 Germany
      • 5.3.2.1 Germany biopharmaceutical excipients market, 2016 - 2027 (USD Million)
    • 5.3.3 U.K.
      • 5.3.3.1 U.K. biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.2 Japan
      • 5.4.2.1 Japan biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.3 China
      • 5.4.3.1 China biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.4 India
      • 5.4.4.1 India biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.5 Malaysia
      • 5.4.5.1 Malaysia biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.6 South Korea
      • 5.4.6.1 South Korea biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.7 Philippines
      • 5.4.7.1 Philippines biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.8 New Zealand
      • 5.4.8.1 New Zealand biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.9 Australia
      • 5.4.9.1 Australia biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.10 Singapore
      • 5.4.10.1 Singapore biopharma excipients market, by revenue 2016 - 2027 (USD Million)
    • 5.4.11 Indonesia
      • 5.4.11.1 Indonesia biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • 5.5 Latin America
    • 5.5.1 Latin America biopharmaceutical excipients market, 2016 - 2027 (USD Million)
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • 5.6 Middle East & Africa (MEA)
    • 5.6.1 Middle East & Africa biopharmaceutical excipients market, 2016 - 2027 (USD Million)
    • 5.6.2 South Africa
      • 5.6.2.1 South Africa biopharmaceutical excipients market, 2016 - 2027 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Strategy Framework
  • 6.2 Market Participation Categorization
  • 6.3 Company Profiles
    • 6.3.1 Merck KGaA
      • 6.3.1.1 Company overview
      • 6.3.1.1.1 Merck Millipore
      • 6.3.1.2 Financial performance
      • 6.3.1.3 Product benchmarking
      • 6.3.1.4 Strategic initiatives
    • 6.3.2 Signet Chemical Corporation Pvt. Ltd.
      • 6.3.2.1 Company overview
      • 6.3.2.2 Financial performance
      • 6.3.2.3 Product benchmarking
      • 6.3.2.4 Strategic initiatives
    • 6.3.3 Sigachi Industries Pvt. Ltd.
      • 6.3.3.1 Company overview
      • 6.3.3.2 Financial performance
      • 6.3.3.3 Product benchmarking
      • 6.3.3.4 Strategic initiatives
    • 6.3.4 Associated British Foods
      • 6.3.4.1 Company overview
      • 6.3.4.2 ABITEC
      • 6.3.4.3 Company overview
      • 6.3.4.4 SPI Pharma
      • 6.3.4.5 Company overview
      • 6.3.4.6 Financial performance
      • 6.3.4.7 Financial performance
      • 6.3.4.7.1 Financial performance
      • 6.3.4.8 Product benchmarking
      • 6.3.4.9 Strategic initiatives
    • 6.3.5 Spectrum Chemical Manufacturing Corp.
      • 6.3.5.1 Company overview
      • 6.3.5.2 Financial performance
      • 6.3.5.3 Product benchmarking
      • 6.3.5.4 Strategic initiatives
    • 6.3.6 Roquette Freres
      • 6.3.6.1 Company overview
      • 6.3.6.2 Financial performance
      • 6.3.6.3 Product benchmarking
      • 6.3.6.4 Strategic initiatives
    • 6.3.7 IMCD
      • 6.3.7.1 Company overview
      • 6.3.7.1.1 Indchem International
      • 6.3.7.2 Financial performance
      • 6.3.7.3 Product benchmarking
      • 6.3.7.4 Strategic initiatives
    • 6.3.8 Clariant
      • 6.3.8.1 Company overview
      • 6.3.8.2 Financial performance
      • 6.3.8.3 Product benchmarking
      • 6.3.8.4 Strategic initiatives
    • 6.3.9 DFE Pharma
      • 6.3.9.1 Company overview
      • 6.3.9.2 Product benchmarking
      • 6.3.9.3 Strategic initiatives
    • 6.3.10 Colorcon
      • 6.3.10.1 Company overview
      • 6.3.10.2 Financial performance
      • 6.3.10.3 Product benchmarking
      • 6.3.10.4 Strategic initiatives
    • 6.3.11 J. RETTENMAIER & SOHNE GmbH + Co KG
      • 6.3.11.1 Company overview
      • 6.3.11.2 JRS PHARMA
      • 6.3.11.3 Company overview
      • 6.3.11.4 Financial performance
      • 6.3.11.5 Product benchmarking
      • 6.3.11.6 Strategic initiatives
    • 6.3.12 BASF SE
      • 6.3.12.1 Company overview
      • 6.3.12.2 Financial performance
      • 6.3.12.3 Product benchmarking
      • 6.3.12.4 Strategic initiatives
    • 6.3.13 Evonik Industries AG
      • 6.3.13.1 Company overview
      • 6.3.13.2 Financial performance
      • 6.3.13.3 Product benchmarking
      • 6.3.13.4 Strategic initiatives

List of Tables

  • TABLE 1 Primary interview details: North America
  • TABLE 2 Primary interview details: Europe
  • TABLE 3 Primary interview details: APAC
  • TABLE 4 Primary interview details: Latin America
  • TABLE 5 Primary interview details: MEA
  • TABLE 6 List of secondary sources
  • TABLE 7 List of top 10 drugs in 2016 by sales
  • TABLE 8 Chemically reactive oxidation products formed by use of Polysorbate 80
  • TABLE 9 The frequency of inclusion of polyols in mAb formulations (%)
  • TABLE 10 North America biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 11 North America biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 12 North America solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 13 North America solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 14 North America polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 15 North America polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 16 North America carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 17 North America carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 18 U.S. biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 19 U.S. biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 20 U.S. solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 21 U.S. solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 22 U.S. polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 23 U.S. polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 24 U.S. carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 25 U.S. carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 26 Canada biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 27 Canada biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 28 Canada solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 29 Canada solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 30 Canada polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 31 Canada polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 32 Canada carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 33 Canada carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 34 Europe biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 35 Europe biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 36 Europe solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 37 Europe solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 38 Europe polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 39 Europe polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 40 Europe carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 41 Europe carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 42 Germany biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 43 Germany biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 44 Germany solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 45 Germany solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 46 Germany polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 47 Germany polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 48 Germany carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 49 Germany carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 50 U.K. biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 51 U.K. biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 52 U.K. solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 53 U.K. solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 54 U.K. polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 55 U.K. polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 56 U.K. carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 57 U.K. carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 58 Asia Pacific biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 59 Asia Pacific biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 60 Asia Pacific solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 61 Asia Pacific solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 62 Asia Pacific polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 63 Asia Pacific polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 64 Asia Pacific carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 65 Asia Pacific carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 66 Top selling biopharmaceuticals in Japan: 2015
  • TABLE 67 Japan biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 68 Japan biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 69 Japan solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 70 Japan solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 71 Japan polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 72 Japan polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 73 Japan carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 74 Japan carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 75 China biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 76 China biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 77 China solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 78 China solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 79 China polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 80 China polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 81 China carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 82 China carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 83 India biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 84 India biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 85 India solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 86 India solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 87 India polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 88 India polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 89 India carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 90 India carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 91 Malaysia: Approved biosimilars
  • TABLE 92 Malaysia biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 93 Malaysia biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 94 Malaysia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 95 Malaysia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 96 Malaysia polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 97 Malaysia polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 98 Malaysia carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 99 Malaysia carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 100 South Korea: Approved Biosimilars
  • TABLE 101 South Korea biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 102 South Korea biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 103 South Korea solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 104 South Korea solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 105 South Korea polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 106 South Korea polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 107 South Korea carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 108 South Korea carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 109 Philippines biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 110 Philippines biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 111 Philippines solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 112 Philippines solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 113 Philippines polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 114 Philippines polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 115 Philippines carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 116 Philippines carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 117 New Zealand biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 118 New Zealand biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 119 New Zealand solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 120 New Zealand solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 121 New Zealand polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 122 New Zealand polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 123 New Zealand carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 124 New Zealand carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 125 Australia biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 126 Australia biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 127 Australia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 128 Australia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 129 Australia polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 130 Australia polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 131 Australia carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 132 Australia carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 133 Singapore biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 134 Singapore biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 135 Singapore solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 136 Singapore solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 137 Singapore polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 138 Singapore polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 139 Singapore carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 140 Singapore carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 141 Indonesia biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 142 Indonesia biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 143 Indonesia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 144 Indonesia solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 145 Indonesia polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 146 Indonesia polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 147 Indonesia carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 148 Indonesia carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 149 Latin America biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 150 Latin America biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 151 Latin America solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 152 Latin America solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 153 Latin America polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 154 Latin America polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 155 Latin America carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 156 Latin America carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 157 Brazil biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 158 Brazil biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 159 Brazil solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 160 Brazil solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 161 Brazil polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 162 Brazil polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 163 Brazil carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 164 Brazil carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 165 Middle East & Africa biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 166 Middle East & Africa biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 167 Middle East & Africa solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 168 Middle East & Africa solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 169 Middle East & Africa polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 170 Middle East & Africa polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 171 Middle East & Africa carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 172 Middle East & Africa carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 173 South Africa biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 174 South Africa biopharmaceutical excipients market estimates & forecasts, by product, 2016 - 2027 (Tons)
  • TABLE 175 South Africa solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 176 South Africa solubilizers & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 177 South Africa polyol excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 178 South Africa polyol excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)
  • TABLE 179 South Africa carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 180 South Africa carbohydrate excipients market estimates & forecasts, by type, 2016 - 2027 (Tons)

List of Figures

  • FIG. 1 Market snapshot
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain based sizing & forecasting
  • FIG. 7 QFD modelling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Commodity flow analysis
  • FIG. 10 Volume price analysis
  • FIG. 11 Market trends & outlook
  • FIG. 12 Market segmentation & scope
  • FIG. 13 Market driver relevance analysis (Current & future impact)
  • FIG. 14 Market restraint relevance analysis (Current & future impact)
  • FIG. 15 Penetration & growth prospect mapping for products, 2019
  • FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 17 Porter's Five Forces Analysis
  • FIG. 18 Global biopharma excipients market: Product outlook key takeaways
  • FIG. 19 Biopharma excipients market: Product movement analysis
  • FIG. 20 Global solubilizers & surfactants/emulsifiers market, by revenue 2016 - 2027 (USD Million)
  • FIG. 21 Global solubilizers & surfactants/emulsifiers market, by volume 2016 - 2027 (Tones)
  • FIG. 22 Global triglycerides market, by revenue 2016 - 2027 (USD Million)
  • FIG. 23 Global triglycerides market, by volume 2016 - 2027 (Tones)
  • FIG. 24 Global esters market, by revenue 2016 - 2027 (USD Million)
  • FIG. 25 Global esters market, by volume 2016 - 2027 (Tones)
  • FIG. 26 Global other solubilizers market, by revenue 2016 - 2027 (USD Million)
  • FIG. 27 Global other solubilizers market, by volume 2016 - 2027 (Tones)
  • FIG. 28 Global polyols market, by revenue 2016 - 2027 (USD Million)
  • FIG. 29 Global polyols market, by volume 2016 - 2027 (Tones)
  • FIG. 30 Global mannitol market, by revenue 2016 - 2027 (USD Million)
  • FIG. 31 Global mannitol market, by volume 2016 - 2027 (Tones)
  • FIG. 32 Global sorbitol market, by revenue 2016 - 2027 (USD Million)
  • FIG. 33 Global sorbitol market, 2016 - 2027 (Tones)
  • FIG. 34 Global other polyols market, by revenue 2016 - 2027 (USD Million)
  • FIG. 35 Global other polyols market, by volume 2016 - 2027 (Tones)
  • FIG. 36 Global carbohydrates market, by revenue 2016 - 2027 (USD Million)
  • FIG. 37 Global carbohydrates market, by volume 2016 - 2027 (Tones)
  • FIG. 38 Global dextrose market, by revenue 2016 - 2027 (USD Million)
  • FIG. 39 Global dextrose market, by volume 2016 - 2027 (Tones)
  • FIG. 40 Global sucrose market, by revenue 2016 - 2027 (USD Million)
  • FIG. 41 Global sucrose market, 2016 - 2027 (Tones)
  • FIG. 42 Global starch market, by revenue 2016 - 2027 (USD Million)
  • FIG. 43 Global starch market, by volume 2016 - 2027 (Tones)
  • FIG. 44 Global other carbohydrates market, by revenue 2016 - 2027 (USD Million)
  • FIG. 45 Global other carbohydrates market, by volume 2016 - 2027 (Tones)
  • FIG. 46 Global specialty excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 47 Global specialty excipients market, by volume 2016 - 2027 (Tones)
  • FIG. 48 Regional market place: Key takeaway
  • FIG. 49 Biopharmaceutical excipients regional outlook, 2019 & 2027
  • FIG. 50 North America biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 51 U.S. biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 52 Canada biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 53 Europe biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 54 Germany biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 55 U.K. biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 56 Asia Pacific biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 57 Japan biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 58 China biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 59 India biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 60 Malaysia biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 61 South Korea biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 62 Philippines biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 63 New Zealand biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 64 Australia biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 65 Singapore biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 66 Indonesia biopharma excipients market, by revenue 2016 - 2027 (USD Million)
  • FIG. 67 Latin America biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 68 Brazil biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 69 Middle East & Africa biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 70 South Africa biopharmaceutical excipients market, 2016 - 2027 (USD Million)
  • FIG. 71 Strategy framework
  • FIG. 72 Participant categorization